Published in Biomed Res Int on June 23, 2014
High Serum Immunoglobulin G and M Levels Predict Freedom From Adverse Cardiovascular Events in Hypertension: A Nested Case-Control Substudy of the Anglo-Scandinavian Cardiac Outcomes Trial. EBioMedicine (2016) 0.81
Novel Immune Mechanisms in Hypertension and Cardiovascular Risk. Curr Cardiovasc Risk Rep (2017) 0.77
Fcγ receptors and ligands and cardiovascular disease. Circ Res (2015) 0.77
Heterogeneity of B Cell Functions in Stroke-Related Risk, Prevention, Injury, and Repair. Neurotherapeutics (2016) 0.75
A controlled trial of renal denervation for resistant hypertension. N Engl J Med (2014) 14.22
Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med (2007) 7.69
CD40 and CD154 in cell-mediated immunity. Annu Rev Immunol (1998) 6.83
B lymphocytes: how they develop and function. Blood (2008) 4.07
T cell-dependent B cell activation. Annu Rev Immunol (1993) 3.81
Renin-angiotensin system: biochemistry and mechanisms of action. Physiol Rev (1977) 3.70
Heat shock proteins. J Biol Chem (1990) 3.64
Inflammation, immunity, and hypertension. Hypertension (2010) 3.43
Voltage-gated calcium channels. Cold Spring Harb Perspect Biol (2011) 3.36
Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest (1999) 3.28
Autoimmune hemolytic anemia. Am J Hematol (2002) 3.01
Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II. Mol Endocrinol (2005) 2.66
Systemic lupus erythematosus: prototype of immune complex nephritis in man. J Exp Med (1971) 2.64
Molecular mimicry and immune-mediated diseases. FASEB J (1998) 2.53
Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial. Circulation (2012) 2.07
Circulating heat shock protein and heat shock protein antibody levels in established hypertension. J Hypertens (2002) 2.05
A novel role for type 1 angiotensin receptors on T lymphocytes to limit target organ damage in hypertension. Circ Res (2012) 1.79
Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy. J Clin Invest (2004) 1.77
Mechanical stress-induced heat shock protein 70 expression in vascular smooth muscle cells is regulated by Rac and Ras small G proteins but not mitogen-activated protein kinases. Circ Res (2000) 1.69
Purification and identification of secreted oxidative stress-induced factors from vascular smooth muscle cells. J Biol Chem (2000) 1.68
Autoimmunity in idiopathic dilated cardiomyopathy. Characterization of antibodies against the beta 1-adrenoceptor with positive chronotropic effect. Circulation (1994) 1.63
Candesartan versus imidapril in hypertension: a randomised study to assess effects of anti-AT1 receptor autoantibodies. Heart (2011) 1.51
Upregulation of L-type Ca2+ channels in mesenteric and skeletal arteries of SHR. Hypertension (2002) 1.49
Alpha1-adrenergic receptors: new insights and directions. J Pharmacol Exp Ther (2001) 1.48
High blood pressure upregulates arterial L-type Ca2+ channels: is membrane depolarization the signal? Circ Res (2004) 1.47
Angiotensin receptor agonistic autoantibody is highly prevalent in preeclampsia: correlation with disease severity. Hypertension (2009) 1.46
Role of the adaptive immune system in hypertension. Curr Opin Pharmacol (2010) 1.44
Human parvovirus B19 infection and autoimmunity. Autoimmun Rev (2008) 1.38
Diagnosis and evaluation of vasculitis. Rheumatology (Oxford) (2000) 1.37
Isotype switching by human B cells is division-associated and regulated by cytokines. J Immunol (2002) 1.36
AUTOIMMUNE FACTORS ASSOCIATED WITH INFARCTION OF THE KIDNEY. Nephron (1964) 1.35
Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension. J Hypertens (2000) 1.26
Molecular mimicry between the immunodominant ribosomal protein P0 of Trypanosoma cruzi and a functional epitope on the human beta 1-adrenergic receptor. J Exp Med (1995) 1.23
Functional autoimmune epitope on alpha 1-adrenergic receptors in patients with malignant hypertension. Lancet (1994) 1.21
Potential relevance of alpha(1)-adrenergic receptor autoantibodies in refractory hypertension. PLoS One (2008) 1.19
Autoantibodies against AT1-receptor and alpha1-adrenergic receptor in patients with hypertension. Hypertens Res (2002) 1.18
Alpha 1-adrenergic receptor antibodies in patients with primary hypertension. Hypertension (1997) 1.18
Activating autoantibodies to the angiotensin II type I receptor play an important role in mediating hypertension in response to adoptive transfer of CD4+ T lymphocytes from placental ischemic rats. Am J Physiol Regul Integr Comp Physiol (2012) 1.17
Physiological role and regulation of the Na+/H+ exchanger. Can J Physiol Pharmacol (2006) 1.16
Prevalence of agonistic autoantibodies against the angiotensin II type 1 receptor and soluble fms-like tyrosine kinase 1 in a gestational age-matched case study. Hypertension (2008) 1.16
L-type calcium channels. Curr Pharm Des (2006) 1.16
Restoration of T cell depression and suppression of blood pressure in spontaneously hypertensive rats (SHR) by thymus grafts or thymus extracts. J Immunol (1982) 1.14
Autoantibody-mediated angiotensin receptor activation contributes to preeclampsia through tumor necrosis factor-alpha signaling. Hypertension (2010) 1.13
Angiotensin receptor agonistic autoantibodies and hypertension: preeclampsia and beyond. Circ Res (2013) 1.13
Antibodies to ribosomal P proteins of Trypanosoma cruzi in Chagas disease possess functional autoreactivity with heart tissue and differ from anti-P autoantibodies in lupus. Proc Natl Acad Sci U S A (1997) 1.10
Regulation of sarcolemmal Na(+)/H(+) exchanger activity by angiotensin II in adult rat ventricular myocytes: opposing actions via AT(1) versus AT(2) receptors. Circ Res (1999) 1.07
Association of elevated serum heat-shock protein 70 concentration with transient hypertension of pregnancy, preeclampsia and superimposed preeclampsia: a case-control study. J Hum Hypertens (2006) 1.07
Immune complexes in human diseases: a review. Am J Pathol (1980) 1.05
Antibodies against the carboxyl-terminal end of the Trypanosoma cruzi ribosomal P proteins are pathogenic. FASEB J (2001) 1.05
Association of plasma antibodies against the inducible Hsp70 with hypertension and harsh working conditions. Cell Stress Chaperones (2001) 1.04
Raised serum IgG levels in hypertension. Br Med J (1970) 1.03
Beta-adrenergic receptor subtypes: properties, distribution, and regulation. Annu Rev Neurosci (1981) 1.02
A two-signal model for regulation of immunoglobulin isotype switching. FASEB J (1992) 1.01
Autoantibody-mediated IL-6-dependent endothelin-1 elevation underlies pathogenesis in a mouse model of preeclampsia. J Immunol (2011) 1.01
Role of angiotensin II type I receptor agonistic autoantibodies (AT1-AA) in preeclampsia. Curr Opin Pharmacol (2011) 1.00
Regulation and localization of HSP70 and HSP25 in the kidney of rats undergoing long-term administration of angiotensin II. Hypertension (2002) 1.00
Acute hypertension induces heat-shock protein 70 gene expression in rat aorta. Circulation (1995) 0.99
Angiotensin II stimulates p90rsk in vascular smooth muscle cells. A potential Na(+)-H+ exchanger kinase. Circ Res (1997) 0.99
Calcium current in smooth muscle cells from normotensive and genetically hypertensive rats. Hypertension (1994) 0.99
Autoantibodies to OxLDL are decreased in individuals with borderline hypertension. Hypertension (1999) 0.98
Enhanced G protein activation in immortalized lymphoblasts from patients with essential hypertension. J Clin Invest (1995) 0.97
Parvovirus B19 infection. Eur J Clin Microbiol Infect Dis (1996) 0.97
Anti-vascular endothelial cell antibodies in severe preeclampsia. Am J Obstet Gynecol (1990) 0.96
Molecular mimicry and myasthenia gravis. An autoantigenic site of the acetylcholine receptor alpha-subunit that has biologic activity and reacts immunochemically with herpes simplex virus. J Clin Invest (1989) 0.95
Long-term immune reconstitution in RAG-1-deficient mice treated by retroviral gene therapy: a balance between efficiency and toxicity. Blood (2005) 0.95
Immune reactivity to heat shock protein 70 expressed in the kidney is cause of salt-sensitive hypertension. Am J Physiol Renal Physiol (2012) 0.95
Augmented calcium currents in mesenteric artery branches of the spontaneously hypertensive rat. Hypertension (1995) 0.94
Hypertensive sodium-proton exchanger phenotype persists in immortalized lymphoblasts from essential hypertensive patients. A cell culture model for human hypertension. J Clin Invest (1993) 0.92
Immunological changes in patients with previous malignant essential hypertension. Lancet (1981) 0.91
Antibody to acetylcholine receptor in myasthenia gravis: prevalence, clinical correlates, and diagnostic value. 1975. Neurology (1998) 0.91
Antibodies from Trypanosoma cruzi infected mice recognize the second extracellular loop of the beta 1-adrenergic and M2-muscarinic receptors and regulate calcium channels in isolated cardiomyocytes. Mol Cell Biochem (1997) 0.90
B-cell-depleting therapy in systemic lupus erythematosus. Am J Med (2012) 0.90
Circulating anti-heat-shock-protein antibodies in normal pregnancy and preeclampsia. Cell Stress Chaperones (2009) 0.87
Membrane sodium-proton exchange and primary hypertension. Hypertension (1993) 0.87
Increase in functional Ca2+ channels in cerebral smooth muscle with renal hypertension. Circ Res (1998) 0.87
Efficacy and safety of sustained-release diltiazem in stable angina pectoris. Am J Cardiol (1986) 0.87
Experimental induction of salt-sensitive hypertension is associated with lymphocyte proliferative response to HSP70. Kidney Int Suppl (2008) 0.87
Single L-type calcium channels in smooth muscle cells from resistance arteries of spontaneously hypertensive rats. Hypertension (1998) 0.85
AT1 receptor-mediated angiotensin II activation and chemotaxis of T lymphocytes. Mol Immunol (2011) 0.85
Antihypertensive mechanisms of beta-adrenoceptor blockade: a review. Clin Exp Hypertens A (1985) 0.84
Circulating oxidized low-density lipoprotein is increased in hypertension. Clin Sci (Lond) (2003) 0.81
Success and failure of vaccines against renin-angiotensin system components. Nat Rev Cardiol (2009) 0.81
Immunization against angiotensins for the treatment of hypertension. Clin Immunol (2009) 0.81
Alpha-adrenergic receptors and blood pressure control. Am J Cardiol (1986) 0.81
Antibodies to endothelial cells in borderline hypertension. Circulation (1998) 0.81
In type 1 diabetes a subset of anti-coxsackievirus B4 antibodies recognize autoantigens and induce apoptosis of pancreatic beta cells. PLoS One (2013) 0.81
Antiendothelial cell antibody levels in healthy normotensives with high normal blood pressure. Clin Exp Hypertens (2006) 0.80
Antiendothelial cell antibody levels in patients with masked hypertension. Int J Cardiol (2008) 0.80
Correlation between HLA-DRB1, HLA-DQB1 polymorphism and autoantibodies against angiotensin AT(1) receptors in Chinese patients with essential hypertension. Clin Cardiol (2011) 0.79
A 90-kD Na(+)-H+ exchanger kinase has increased activity in spontaneously hypertensive rat vascular smooth muscle cells. Hypertension (1997) 0.79
A novel autoantibody in patients with primary hypertension: antibody against L-type Ca2+ channel. Chin Med J (Engl) (2008) 0.78
Enhanced immunoglobulin formation of immortalized B cells from hypertensive patients. Hypertension (1995) 0.78
Increased secretion of immunoglobulins in malignant hypertension. J Hypertens (1989) 0.78
Pathogen burden in essential hypertension. Circ J (2007) 0.78
Vaccines in the management of hypertension. Expert Opin Biol Ther (2010) 0.77
The sera of spontaneously hypertensive rats contain agonistic auto-antibodies against the beta 1-adrenoceptor. J Hypertens (1995) 0.77
Influence of autoantibodies against AT1 receptor and AGTR1 polymorphisms on candesartan-based antihypertensive regimen: results from the study of optimal treatment in hypertensive patients with anti-AT1-receptor autoantibodies trial. J Am Soc Hypertens (2013) 0.77
Increased serum IgG levels in essential hypertension. Immunol Lett (1984) 0.77